Guselkumab and il-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis: 6-month interim results of the psabiond observational cohort study
| dc.contributor.author | Gossec, Laure | |
| dc.contributor.author | Sharaf, Mohamed | |
| dc.contributor.author | Baraliakos, Xenofon | |
| dc.contributor.author | Kishimoto, Mitsumasa | |
| dc.contributor.author | Lubrano, Ennio | |
| dc.contributor.author | Rahman, Proton | |
| dc.contributor.author | Rampakakis, Emmanouil | |
| dc.contributor.author | Koleseri, Laszlo | |
| dc.contributor.author | Koivunen, Minni | |
| dc.contributor.author | Lavie, Frederic | |
| dc.contributor.author | Soriano, Enrique R. | |
| dc.contributor.author | Queiro Silva, Rubén | |
| dc.contributor.author | Behrens, Frank | |
| dc.contributor.author | Siebert, Stefan | |
| dc.date.accessioned | 2025-04-30T09:20:16Z | |
| dc.date.available | 2025-04-30T09:20:16Z | |
| dc.date.issued | 2024 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.issn | 2326-5205 | |
| dc.identifier.uri | https://hdl.handle.net/10651/78742 | |
| dc.format.extent | p. 2973-2976 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Arthritis & Rheumatology | |
| dc.rights | ©, | |
| dc.source | WOS:001331419104200 | |
| dc.title | Guselkumab and il-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis: 6-month interim results of the psabiond observational cohort study | |
| dc.type | conference output |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||